Who are Metamizole and Acetaminophen iv's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/metamizole-and-acetaminophen-iv.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Metamizole and Acetaminophen iv — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Metamizole and Acetaminophen iv (Metamizole and Acetaminophen iv) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Non-opioid analgesic and antipyretic combination. Area: Pain Management, Fever Management.

phase 3 Non-opioid analgesic and antipyretic combination Cyclooxygenase (COX) enzymes; central pain and temperature regulation pathways Pain Management, Fever Management Small molecule Live · refreshed every 30 min

Target snapshot

Metamizole and Acetaminophen iv (Metamizole and Acetaminophen iv) — Hospital General Universitario Elche. Metamizole and acetaminophen are non-opioid analgesics and antipyretics that inhibit prostaglandin synthesis and modulate pain perception to reduce fever and pain.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Metamizole and Acetaminophen iv TARGET	Metamizole and Acetaminophen iv	Hospital General Universitario Elche	phase 3	Non-opioid analgesic and antipyretic combination	Cyclooxygenase (COX) enzymes; central pain and temperature regulation pathways

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Non-opioid analgesic and antipyretic combination class)

Hospital General Universitario Elche · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Metamizole and Acetaminophen iv — Competitive Intelligence Brief. https://druglandscape.com/ci/metamizole-and-acetaminophen-iv. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab